Regulatory aspects of modified release dosage forms: in vivo/in vitro correlations
Siewert, M.
Bollettino Chimico Farmaceutico 132(1): 10-22
1993
ISSN/ISBN: 0006-6648 PMID: 8476552 Document Number: 421353
Document emailed within 1 workday
Related Documents
Balant, L.P. 1993: Regulatory aspects of modified release dosage forms: clinical studies Bollettino Chimico Farmaceutico 132(5): 143-149Möller, H.; Wirbitzki, E. 1993: Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system Bollettino Chimico Farmaceutico 132(4): 105-115
Brock, M.H.; Dansereau, R.J.; Patel, V.S. 1994: Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms PharmacoTherapy 14(4): 430-437
Feldmann, E.G. 1986: Modified-release dosage forms American Journal of Hospital Pharmacy 43(10): 2565-2566
Sznitowska, M.łg.; Cal, K.; Kupiec, K. 2004: Development of modified-release dosage forms containing loratadine and pseudoephedrine sulfate Acta Poloniae Pharmaceutica 61 Suppl: 72-74
Lin, S.Y.; Yang, J.C. 1989: In-vitro dissolution behavior of some sustained-release theophylline dosage forms Pharmaceutica Acta Helvetiae 64(8): 236-240
Ritschel, W.A.; Koch, H.P.; Alcorn, G.J. 1984: In vivo-in vitro correlations with sustained-release theophylline preparations Methods and Findings in Experimental and Clinical Pharmacology 6(10): 609-618
Halsas, M.; Penttinen, T.; Veski, P.; Jürjenson, H.; Marvola, M. 2001: Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations Die Pharmazie 56(9): 718-723
Gurny, R.; Buri, P.; Sucker, H.; Guitard, P.; Leuenberger, H. 1977: Production and theoretical development of dosage forms having release controlled by metacrylic films. 4. Multiple linear regression study of technological factors influencing the release of an active principle from microgranules encased by fluidization Pharmaceutica Acta Helvetiae 52(10): 247-251
Sandler, M.; Carter, S.B.; Goodwin, B.L.; Ruthven, C.R.; Youdim, M.B.; Hanington, E.; Cuthbert, M.F.; Pare, C.M. 1974: Multiple forms of monoamine oxidase: some in vivo correlations Advances in Biochemical Psychopharmacology 12: 3-10
Civiale, C.; Ritschel, W.A.; Shiu, G.K.; Aiache, J.M.; Beyssac, E. 1991: In vivo-in vitro correlation of salbutamol release from a controlled release osmotic pump delivery system Methods and Findings in Experimental and Clinical Pharmacology 13(7): 491-498
Skelly, J.P.; Van Buskirk, G.A.; Savello, D.R.; Amidon, G.L.; Arbit, H.M.; Dighe, S.; Fawzi, M.B.; Gonzalez, M.A.; Malick, A.W.; Malinowski, H. 1993: Scale-up of immediate release oral solid dosage forms. AAPS/FDA Workshop Committee Report Journal of parenteral science and technology: a publication of the Parenteral Drug Association 47(2): 52-56
Gul, R.; Jan, S.U.; Ahmed, M.; Akhtar, M.; Qureshi, M.M. 2019: Formulation, characterization and in vivo evaluation of Hedera helix L., topical dosage forms Pakistan Journal of Pharmaceutical Sciences 32(6): 2605-2610
Förster, H.; Lippold, B.C. 1982: Conception of peroral sustained-release dosage forms: calculation of initial and maintenance dose with consideration of accumulation Pharmaceutica Acta Helvetiae 57(12): 345-349
Trautlein, J.J.; Demers, L.; Esler, V.; Field, E. 1981: Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma Clinical Therapeutics 4(4): 252-262
Horwitz, W.; Albert, R.H. 1985: Performance characteristics of methods of analysis used for regulatory purposes. I. Drug dosage forms. D. High pressure liquid chromatographic methods Journal - Association of Official Analytical Chemists 68(2): 191-198
Rak, J.; Hároníková, K. 1980: Worldwide aspects of teaching the subject, "dosage forms" Ceskoslovenska Farmacie 29(10): 329-331
Rees, J.E. 1977: "in vitro" dissolution tests for solid oral dosage forms Bollettino Chimico Farmaceutico 116(9): 499-505
Vattikonda, C.S.; Ritschel, W.A.; Herbert, C. 1994: Biopharmaceutic approach in designing a controlled release tablet of sodium monofluoro phosphate. Characterization of absorption sites and evaluation of modified dosage form International Journal of Clinical Pharmacology and Therapeutics 32(10): 559-566
Gielsdorf, W.; Nieder, M.; Molz, K.H.; Jaeger, H.; Haerlin, R.; Radtke, H.W. 1986: The pharmacokinetics and bioavailability of urapidil. in vitro/in vivo correlations of different experimental formulations Arzneimittel-Forschung 36(8): 1265-1267